June 16, 2022 – June 16, 2022 – The paper “How to boost Ontario’s life sciences IP to help patients and the economy” discusses the importance of seed-stage investing and commercialization-venture partnerships to reap the benefits of taxpayers’ investment in post-secondary education and health research.
Read More from FACIT’s David O’Neill shares strategy for Ontario intellectual property
April 28, 2022 – Early-stage capital positions science and intellectual property for Ontario economic impact April 27, 2022 – FACIT announced two recent strategic investments from its Prospects Oncology Fund in innovations arising from renowned cancer experts at the Ontario Institute for Cancer Research (OICR): Dr. Rima Al-awar, Head of Therapeutic Innovation and Drug Discovery, and Dr. Lincoln Stein, Head
February 4, 2022 – Annual event showcases emerging entrepreneurs and FACIT’s commitment to advance Ontario’s most promising oncology innovations February 4, 2022 – FACIT, a commercialization venture firm for Ontario cancer innovations, is pleased to announce the 2022 winner of its Falcons’ Fortunes pitch competition: Point Surgical Inc.. Point Surgical was founded as a joint venture between Toronto’s University Health
January 27, 2022 – January 27, 2022 – FACIT congratulates portfolio company Cellular Analytics on a recent publication by its CSO, Dr. Shana Kelley and collaborators, on the Company’s tumor-infiltrating lymphocyte (TIL) therapeutics platform.
January 11, 2022 – Now in its 9th year, the FACIT Falcons’ Fortunes event is back for 2022! Be part of the audience and watch the six finalists pitch their Ontario oncology innovations.
Read More from Registration is now open for FACIT Falcons’ Fortunes virtual pitch competition
January 11, 2022 – Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it.
November 30, 2021 – The appointment broadens the available expertise to provide critical senior management and leadership to create and nurture FACIT start-ups in Ontario.
Read More from FACIT broadens Executive-in-Residence program to capitalize on Ontario IP
October 21, 2021 – Radiant received a seed investment from FACIT’s Compass Rose Oncology Fund.
October 13, 2021 – Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it.
September 16, 2021 – Both innovations were previous finalists in FACIT’s 2021 Falcons’ Fortunes pitch competition.